Vitiligo Research Foundation
Advances in metabolic research have positioned glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as a promising therapeutic option for MASH, extending their use beyond diabetes and obesity management
Surgeons employ it as a vivid blue dye during procedures, for example, to map sentinel lymph nodes in breast cancer surgery or to identify parathyroid glands, taking advantage of its visible staining properties
Formulary Dynamics, Rebates, and the Payer-Driven Biosimilar Market Manufacturing cost and regulatory status determine the floor of biosimilar commercial viability
Whether its travel, changes in diet or exercise, or the development of new health conditions, your healthcare provider will help you navigate these changes to ensure your semaglutide treatment remains safe and effective